Outcomes in patients with atypical hemolytic uremic syndrome treated with eculizumab in a long-term observational study. [electronic resource]
- BMC nephrology 04 2019
- 125 p. digital
Publication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't
1471-2369
10.1186/s12882-019-1314-1 doi
Adolescent Adult Antibodies, Monoclonal, Humanized--administration & dosage Atypical Hemolytic Uremic Syndrome--complications Child Complement Inactivating Agents--administration & dosage Female Follow-Up Studies Glomerular Filtration Rate Humans International Cooperation Long Term Adverse Effects--diagnosis Male Medication Therapy Management Outcome and Process Assessment, Health Care Thrombotic Microangiopathies--diagnosis